Scilex Holding Co
SCLX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001820190
No open-market purchases or sales by Scilex Holding Co insiders were filed in the last 90 days; 73 institutions reported holding it in 13F filings for Q2 2026, worth $5.48M in total; no superinvestor holds it.
Other share classesSCLXW
Q2 2025 vs. Q1 2025
How the institutions holding Scilex Holding Co changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 85 | 1 | 69 | −15 |
| SharesConverted for a 1-for-35 split | 1.30M | 28.2 | 635.3K | −661.4K (−51.0%) |
| Value | $11.3M | $245 | $3.72M | −$7.55M (−67.0%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (33)
Institutions that held Scilex Holding Co at the end of Q2 2025 but not at the end of Q1 2025.
Sold out (48)
Institutions that held Scilex Holding Co at the end of Q1 2025 and filed for Q2 2025 without it.
Not filed for Q2 2025 yet (1)
Institutions that held Scilex Holding Co at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Credit Agricole S A | 987 | $245 |